Results

Total Results: 2,111 records

Showing results for "risk".

321. Cannabis-2022-Update-Surv-Rep-1-Apps-G1-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-apps-G1-2.xlsx
     January 01, 2022 - Risk of bias of cannabis RCTs Author, Year Randomization Adequate? … Risk of bias of cannabis RCTs Table G-2. ROB Cohort Studies Table G-2. … Risk of bias of cannabis cohort studies Author, Year Did the Study Attempt to Enroll All (or a Random … Risk of Bias Bestard, 2011 Yes Yes Yes No Yes Yes/No No Yes Moderate Campbell, 2018 Yes Unclear Yes … Risk of bias of cannabis cohort studies image1.jpeg image2.jpeg

322. Outcomes in COPD patients treated with theophylline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
     December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease patients using theophylline. … Compared to similar regimens, patients in regimens that included theophylline had slightly increased risks … these increased risks were generally small (HR of 1.1 to 1.3). … patient-reported outcomes in a real-world setting will be necessary to quantify both the benefits and risks … Inhaled corticosteroids and the risk of a first exacerbation in COPD patients.

323. Outcomes in COPD patients treated with theophylline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
     December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease patients using theophylline. … Compared to similar regimens, patients in regimens that included theophylline had slightly increased risks … these increased risks were generally small (HR of 1.1 to 1.3). … patient-reported outcomes in a real-world setting will be necessary to quantify both the benefits and risks … Inhaled corticosteroids and the risk of a first exacerbation in COPD patients.

324. Omega-3 Fatty Acids and Cardiovascular Disease: A Review of the Research for Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_consumer.pdf
     July 01, 2017 - People with high triglyceride levels may also be at risk for CV disease. … May lower the risk (in healthy people) Do not lower the risk (in people with CV disease or those … at risk for CV disease) Not enough research to know Triglyceride level? … High levels of good cholesterol lower the risk of CV disease. … High levels of bad cholesterol increase the risk of CV disease.

325. Traumatic Brain Injury and Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
     April 01, 2011 - which treatment modalities are equivalent or superior with respect to benefits, short- and long-term risks … Risk factors. Data are sparse to assess whether severity of injury influences risk of depression. … , such that those age 60 and older were at lowest risk.125 In another study aiming at predicting risk … (relative risk [RR] = 1.27; 95 percent confidence interval [CI]: 1.07, 1.52) of new but not recurrent … with risk.

326. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol.pdf
     January 31, 2023 - assess risk of bias of included studies. … Each study will be dual reviewed for risk of bias by two team members. … points on a 0 to 100-point scale • SMD >0.8 • RR/OR ≥2.0 MD = mean difference; OR = odds ratio; RR = relative … The social ecology of community and neighborhood and risk for antisocial behavior. … Assessing the Risk of Bias in Systematic Reviews of Health Care Interventions.

327. Medication-Therapy-Management Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
     November 01, 2014 - A broadly defined scope for this review risks including studies that may be too different from each … A narrowly defined scope for this review risks the omission of studies that met the definition of MTM … In other words, we evaluated trials with potential randomization failure for the same risks of bias … therapy management; NA = not applicable; OR = odds ratio; RCT = randomized controlled trial; RRR = relative … risk ratio.

328. Crosscutting-Horizon-Scan-High-Impact-1512 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - is an example of an initiative aimed at improving surgical outcomes by assessing patient-specific risks …  Key Expert Comments: Programs such as MSHOP may address an unmet need for reducing surgical risks … that clinicians would be likely to adopt a MSHOP-like program based on the potential to decrease risks … Unmet need and health outcomes: An unmet need exists to decrease surgical risks and complications, … biggest hurdle, which is patient compliance.68 Acceptance and adoption: The potential to decrease risks

329. Rheumatoid-Arthritis-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
     April 01, 2012 - Many questions remain about the risks of these agents across a spectrum of adverse events, from relatively … Finally, very little is known about the benefits or risks of these drugs in different patient subgroups … Low Risk for injection site reactions apparently highest with anakinra. … Low Mixed evidence on differences in the risk for rare but severe adverse events. … Biologics neither decreased nor increased cardiovascular risks in the elderly.

330. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
     April 18, 2012 - Evidence-based Practice Center Systematic Review Protocol Project Title: Strategies To Improve Cardiovascular Risk … second-generation antipsychotics) also may contribute to the development of CVD by increasing the risk … Comorbid Risk Factors in People With SMI Pharmacological Treatments Patient-Focused Behavioral … CVD Analytic Framework for Strategies To Improve Cardiovascular Risks Factors in People With Serious … Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study.

331. Suicidal-Thoughts-Young-People-Amendement-May-2025 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-amendement-may-2025.pdf
     January 01, 2025 - to inform the implementation of interventions for children, adolescents, and young adults at high risk … Assessment of the Risk of Bias of Individual Studies We will evaluate the risk of bias of the included … of available studies (in a particular comparison) have high or unclear risk of bias. … How have the SSRI antidepressants affected suicide risk? … RoB 2: a revised tool for assessing risk of bias in randomised trials.

332. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
     January 01, 2007 - Many questions remain about the risks of these agents across a spectrum of adverse events from relatively … Finally, very little is known about the benefits or risks of these drugs in different patient subgroups … All the same issues noted for RA of short- and long-term risks and safety, as well as performance in … withdrawals attributed to adverse events were not significantly different for leflunomide vs. methotrexate (relative … risk [RR], 1.19; 95-percent CI, 0.89-1.6) or sulfasalazine (RR, 0.77; 95-percent CI, 0.45-1.33).

333. S13 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
     October 01, 2007 - Historically, those who investigate the effects of mar- keted pharmaceuticals have focused on the risk … Finally, in recent years, there has been an increased focus on risk management of drugs (ie, modifi- … Variation in risk can also depend on duration. … Patterns of risk related to last exposure can also vary. … Managing the risks from medical product use: creating a risk management framework. http://www.fda. gov

334. S123 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
     October 01, 2007 - ORIGINAL ARTICLE Heterogeneity and the Interpretation of Treatment Effect Estimates From Risk Adjustment … Results: Risk adjustment models yielded average survival estimates similar to trial results. … Both confounding risks and the extent that the estimates can be generalized across the patient population … curve. 0 UO optimistic BCSI relative survival risk curve. … Table 3 contains the risk adjusted linear probability model and the IV survival models.

335. Research Review Title: Infection Prevention and Control for the Emergency Medical Services and 911 Workforce (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-disposition-comments.pdf
     November 01, 2022 - examined the risk for COVID-19 infection among EMS providers in King County, Washington. … of COVID-19 infection and that overall risk to EMS providers was very low. … " in fact some studies say lower risk than the general public. … Example - medical waste studies do not show that medical waste poses a risk. … , proper patient care risk reduction practices as well as personal protection.

336. Antipsychotics for the Prevention and Treatment of Delirium: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
     June 01, 2018 - Older age is an important independent risk factor for delirium,2 with a prevalence >70% in critically … higher heterogeneity.24 For dichotomous outcomes, we will calculate a pooled effect estimate of the relative … A systematic review of risk factors for delirium in the ICU. … Does antipsychotic drug use increase the risk of long term mortality? … ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

337. Evidence Summary for CER 239: Acute Treatments for Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
     December 01, 2020 - inflammatory drugs), dihydroergotamine, antiemetics, and acetaminophen, reduce pain but increase the risk … • No studies evaluate instruments for predicting risk of opioid misuse, opioid use disorder or overdose … , or evaluate risk mitigation strategies to be used when prescribing opioids for episodic migraine … overdose; or evaluated risk mitigation strategies in episodic migraine. … For example, lasmiditan increased the risk of serious adverse events compared with placebo.

338. Disposition of Comments_Comparative Effectiveness Review No. 248: Prehabilitation and Rehabilitation for Major Joint Replacement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/joint-replacement-disposition-comments.pdf
     November 03, 2021 - • Clarification of risk-of-bias assessment: Several reviewers noted the challenges in achieving a … low-risk-of-bias rating, particularly given the challenge of blinding personnel and patients. … We noted that while the evidence from high-risk-of-bias studies should be considered cautiously, a … high-risk-of-bias rating does not mean such studies have no evidentiary value or that they are intrinsically … We followed AHRQ methods to not remove studies deemed to be at high risk of bias, but present the risk

339. Methods Guide for Medical Test Reviews Chapter 11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
     July 01, 2012 - What health risks can be identified for follow-up testing and/or intervention? 35. … Tests for BRCA mutations may be used to predict the risk for breast and ovarian cancer in high-risk … women (i.e., those with a family history suggesting increased risk). … Lyon, France: IARC Monogr Eval Carcinog Risks Hum; 1999. p. 23-36. 45. … Genetic risk assessment: recommendation statement.

340. Nonpharmacologic Treatment for Maternal Mental Health Conditions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-pregnant-protocol.pdf
     August 24, 2023 - Assessment of Methodological Risk of Bias of Individual Studies: We will evaluate each study for risk … Depression and anxiety in early pregnancy and risk for preeclampsia. … Untreated prenatal maternal depression and the potential risks to offspring: a review. … We will not assess risk of bias for these studies; except that we will assess risk of bias of large … study for risk of bias and methodological quality.